Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186264 · ClinicalTrials.gov registry record · NA
Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00186264: Completed NA study, sponsored by Stanford University.
NCT00186264 is a NA study that has completed, run by Stanford University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186264, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The primary purpose of this study is to examine whether IV hydrocortisone can speed up the time required for Venlafaxine XR to work.
Interventions
- DRUG venlafaxine XR
- DRUG hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186264
The ClinicalTrials.gov registry entry for NCT00186264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which venlafaxine XR is the first listed.
NCT00186264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186264 about?
NCT00186264 is a clinical study titled "Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?". The primary purpose of this study is to examine whether IV hydrocortisone can speed up the time required for Venlafaxine XR to work.
What is the current status of trial NCT00186264?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2002-08. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00186264?
The interventions under investigation include: venlafaxine XR (DRUG), hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT00186264?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.